Nishikawa A, Furukawa F, Imazawa T, Yoshimura H, Ikezaki S, Hayashi Y, Takahashi M
Division of Pathology, National Institute of Health Sciences, Tokyo.
Jpn J Cancer Res. 1994 Oct;85(10):1000-4. doi: 10.1111/j.1349-7006.1994.tb02897.x.
Influences of cigarette smoke on N-nitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic duct and respiratory tract tumorigenesis were investigated using a hamster two-stage carcinogenesis model. Male 5-week-old hamsters were divided into 5 groups. Group 1 was s.c. injected with BOP at a dose of 10 mg/kg once a week for 3 weeks as an initiation treatment together with cigarette smoke exposure over the same 4-week period. Group 2 was exposed to cigarette smoke for 26 weeks after the BOP-initiation. Groups 3 and 4 were respectively given the BOP-initiation alone and the 26-week cigarette smoke exposure without initiation. Group 5 served as a sham-smoked negative control. The experiment was terminated 30 weeks after the first BOP injection. The incidence of pancreatic adenocarcinomas was significantly decreased in Group 1 as compared to the Group 3 value (P < 0.01) while the Group 2 value did not show any change. In contrast, the incidence of laryngeal and tracheal proliferative lesions (hyperplasias and papillomas) was significantly increased in Group 2 over Group 3 (P < 0.01). The incidence of pulmonary hyperplasias was also increased in Group 2 over Group 3 (P < 0.05), although that of pulmonary adenomas or adenocarcinomas was decreased in Group 2 as compared to the Group 3 value (P < 0.01). Cigarette smoke exposure in the BOP-initiation phase (Group 1) did not affect the development of respiratory proliferative lesions. No animals in Groups 4 and 5 developed any tumors in the pancreas or respiratory tract. Our results thus indicate that cigarette smoke exposure inhibits pancreatic carcinogenesis when given in the initiation phase, whereas it modulates (enhances or suppresses) the development of proliferative lesions in the respiratory tract if applied during the promotion stage to hamsters pretreated with BOP.
使用仓鼠两阶段致癌模型,研究了香烟烟雾对N-亚硝基双(2-氧代丙基)胺(BOP)诱导的胰腺导管和呼吸道肿瘤发生的影响。将5周龄雄性仓鼠分为5组。第1组皮下注射剂量为10mg/kg的BOP,每周1次,共3周作为启动处理,同时在相同的4周期间暴露于香烟烟雾。第2组在BOP启动后暴露于香烟烟雾26周。第3组和第4组分别单独给予BOP启动和26周香烟烟雾暴露但无启动处理。第5组作为假吸烟阴性对照。在首次注射BOP后30周终止实验。与第3组相比,第1组胰腺腺癌的发生率显著降低(P<0.01),而第2组的值未显示任何变化。相反,第2组喉和气管增殖性病变(增生和乳头状瘤)的发生率比第3组显著增加(P<0.01)。第2组肺增生的发生率也比第3组增加(P<0.05),尽管与第3组相比,第2组肺腺瘤或腺癌的发生率降低(P<0.01)。在BOP启动阶段暴露于香烟烟雾(第1组)不影响呼吸道增殖性病变的发展。第4组和第5组没有动物在胰腺或呼吸道发生任何肿瘤。因此,我们的结果表明,在启动阶段暴露于香烟烟雾可抑制胰腺癌的发生,而如果在促进阶段应用于经BOP预处理的仓鼠,则它会调节(增强或抑制)呼吸道增殖性病变的发展。